Clin2
NCT05017649Possibly a fitRecruiting

Study of a receptor in people with high LDL cholesterol

Hypercholesterolemia

Treatments studied

Part of Hormones & metabolism clinical trials.

This study looks at how a body receptor (called the A2A receptor) works in people with high “bad” cholesterol (LDL). It compares people with high LDL to people with normal LDL to better understand cholesterol-related biology.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
150 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • Be between 18 and 80 years old
  • Have a recent blood test (within the last 12 months) showing your LDL cholesterol level
  • If you have high LDL: your LDL must be above 1.9 g/L (with or without cholesterol treatment)
  • If your LDL is normal: you must have LDL below 1.9 g/L and not take cholesterol-lowering medicines
  • Either live in France with social security coverage (a social security plan) and agree to sign consent

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT00353782Recruiting
Study of cholesterol and triglyceride problems over time

This study looks at how cholesterol and triglyceride levels change in people with dyslipidemia (unhealthy cholesterol/fat levels). Researchers want to understand what different causes mean for long-term health.

Bethesda, Maryland
NCT06634160Recruiting
Fatty liver disease in people with high cholesterol

This study checks how common fatty liver disease is in people with a genetic form of high cholesterol. It may help researchers understand the link between these two conditions.

Angers
NCT07074236Not yet recruiting· Phase 1
Study of a new cholesterol drug in healthy adults

This study tests how a new drug moves through the body and affects cholesterol levels. It is for people with moderately high cholesterol who are otherwise healthy.

Qingdao
NCT06750341Not yet recruiting· Phase 2
Study of QLC7401 for high cholesterol

This trial tests an experimental drug, QLC7401, for people with high LDL cholesterol that hasn't lowered enough with current treatments. It aims to see if the drug can help reduce cholesterol levels in patients who are already on stable cholesterol medication.

NCT07353398Not yet recruiting· Early Phase 1
Early study of ART002g1 for inherited high cholesterol

This trial tests a new injection called ART002g1 for people with a genetic condition that causes very high cholesterol. It aims to see if the drug is safe and can help lower cholesterol levels.

Shanghai
NCT06676046Recruiting
Study of rare cholesterol and fat disorders

This study looks at people with rare or unusual cholesterol, fat, or heart-related conditions. It helps researchers learn more about these disorders and improve testing. You do not need to have a known diagnosis to join initially.

Bethesda, Maryland

Hear when a new Hypercholesterolemia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.